house committee passes drug safety overhaul washington a legislative package that would overhaul drug safety rules unanimously passed the house energy and commerce committee the bills would give the food and drug administration new powers to regulate drugs after they go on the market and increase fees paid by drug and medical device companies the package now goes to the full house which is expected to approve it next month from there differences must be reconciled with a similar bill passed in the senate both bills are aimed at giving the fda greater authority to track safety problems after drugs are on the market order label changes and require drug makers to conduct additional studies the senate bill would require drug firms to pay an additional &# million and the house bill would require an additional &# million over five years 
